These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12528387)

  • 21. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
    Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
    Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of hepatitis B screening in a mental health institution.
    Leonard J; Holtgrave DR; Johnson RP
    J Fam Pract; 1991 Jan; 32(1):45-8. PubMed ID: 1824638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A simplified financial cost-effectiveness analysis of programs for prevention of hepatitis B accidental inoculation among hospital personnel in Thailand.
    Chongsuvivatwong V
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):189-93. PubMed ID: 2532789
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occupational exposure to hepatitis B virus. Analysis of indications for hepatitis B vaccine.
    Lohiya G; Lohiya S; Caires S; Reesal MR
    J Occup Med; 1984 Mar; 26(3):189-96. PubMed ID: 6232354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The use of decision making analysis for evaluating hepatitis B inoculation strategy].
    Zhuang GH; Xu HW
    Zhonghua Yu Fang Yi Xue Za Zhi; 1993 Mar; 27(2):69-73. PubMed ID: 8354107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost-effectiveness analysis of hepatitis B vaccination in People's Liberation Army].
    Hu R; Cao W; Zhang X
    Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Apr; 22(2):142-5. PubMed ID: 11860866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cost-benefit analysis on immunization of newborns with hepatitis B vaccine in Jinan City].
    Liu ZG; Zhao SL; Zhang YX
    Zhonghua Liu Xing Bing Xue Za Zhi; 1995 Apr; 16(2):81-4. PubMed ID: 7781052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW; Ortega-Sanchez IR; Scott RD; Rosenstein NE;
    Pediatrics; 2005 May; 115(5):1220-32. PubMed ID: 15867028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Vaccination against hepatitis B in Switzerland: towards a global strategy].
    Kammerlander R; Vaudaux B; Bourquin C; Zimmermann HP; Raeber PA
    Rev Med Suisse Romande; 1998 Apr; 118(4):335-9. PubMed ID: 9623285
    [No Abstract]   [Full Text] [Related]  

  • 30. [Health and economic benefits of compulsory regular vaccination in the Slovak Republic. I. Methods].
    Hudecková H; Straka S
    Epidemiol Mikrobiol Imunol; 2000 Feb; 49(1):24-7. PubMed ID: 10802948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Studies on immunization strategies for hepatitis B in different endemic areas of China].
    Wang L; Li H; Wang S; Gong J; Zeng X; Li R; Nong Y; Huang Y; Chen X; Huang Z
    Zhonghua Yu Fang Yi Xue Za Zhi; 1999 Mar; 33(2):104-6. PubMed ID: 11864465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaco-economic evaluation of targeted hepatitis A vaccination for children of ethnic minorities in Amsterdam (The Netherlands).
    Postma MJ; Bos JM; Beutels P; Schilthuis H; van den Hoek JA
    Vaccine; 2004 May; 22(15-16):1862-7. PubMed ID: 15121296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The costs of hepatitis B vaccination: a re-evaluation].
    van de Ven AA; van Hattum J; Willers JM
    Ned Tijdschr Geneeskd; 1990 Feb; 134(6):298-301. PubMed ID: 2137560
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
    Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
    Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F; Santoli J; Messonnier ML; Yusuf HR; Shefer A; Chu SY; Rodewald L; Harpaz R
    Arch Pediatr Adolesc Med; 2005 Dec; 159(12):1136-44. PubMed ID: 16330737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regional variation in the cost effectiveness of childhood hepatitis A immunization.
    Jacobs RJ; Greenberg DP; Koff RS; Saab S; Meyerhoff AS
    Pediatr Infect Dis J; 2003 Oct; 22(10):904-14. PubMed ID: 14551492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B vaccination of blood donors--a cost-benefit analysis.
    Gesemann M; Gentner P; Scheiermann N
    Beitr Infusionsther Transfusionsmed; 1994; 32():110-2. PubMed ID: 9422105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The global impact of vaccination against hepatitis B: a historical overview.
    Zanetti AR; Van Damme P; Shouval D
    Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies.
    Ni YH; Huang LM; Chang MH; Yen CJ; Lu CY; You SL; Kao JH; Lin YC; Chen HL; Hsu HY; Chen DS
    Gastroenterology; 2007 Apr; 132(4):1287-93. PubMed ID: 17433322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age].
    Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.